Clinical Dilemmas in Inflammatory Bowel DiseasePeter Irving, MD, MRCP, David Rampton, Fergus Shanahan Evidence-based guidance to answer more than 60 controversial clinical questions on inflammatory bowel disease Clinical Dilemmas in Inflammatory Bowel Disease is a practical handbook providing quick but detailed answers to the questions and challenges that you are faced with daily in the clinical setting. Each short chapter addresses a different topic and provides evidence-based guidance on subjects ranging from optimising current management through to special management problems and novel treatments. This book is suitable for all medical professionals involved in the care of patients with IBD: established and trainee gastroenterologists, colorectal surgeons, pathologists, radiologists, specialist nurses, pharmacists, dieticians and counsellors |
Contents
| 1 | |
Inflammatory Bowel Disease Part 2 Medical Treatment Making the Most of What Weve Got 5ASA drugs | 21 |
Inflammatory Bowel Disease Part 3 Medical Treatment Whats Round the Corner? | 81 |
Inflammatory Bowel Disease Part 4 Common Clinical Challenges Beyond the Text Book | 125 |
Inflammatory Bowel Disease Part 5 Managing IBD Outside the Gut | 193 |
Inflammatory Bowel Disease Part 6 Are You Sure its IBD? | 217 |
Inflammatory Bowel Disease Part 7 The IBD Service Time for a Rethink? | 229 |
| 241 | |
Other editions - View all
Clinical Dilemmas in Inflammatory Bowel Disease Peter Irving, MD, MRCP,David Rampton,Fergus Shanahan No preview available - 2008 |
Clinical Dilemmas in Inflammatory Bowel Disease Peter Irving, MD, MRCP,David Rampton,Fergus Shanahan No preview available - 2006 |
Common terms and phrases
6-mercaptopurine acid active Crohn’s disease Aliment Pharmacol anti-inflammatory anti-TNF antibiotics antibodies appendectomy arthritis assessment associated azathioprine biopsies cancer cells chronic Clin clinical trials colectomy colonic colonoscopy colorectal controlled trial corticosteroids Crohn’s disease cyclosporine diagnosis diarrhea disease activity dose double-blind drugs dysplasia effects efficacy endoscopic evidence follow-up Gastroenterol 2004 Gastroenterology gastrointestinal genetic heparin hepatitis Hospital HSCT IBD patients ileal immunosuppressive increased indeterminate colitis infection Inflamm Bowel inflammatory bowel disease infliximab infusion reactions intestinal intravenous LEARNING POINTS lesions liver London UK mesalazine methotrexate mg/kg mucosal necrosis factor NSAIDs nutrition oral outcome patients with active patients with Crohn’s patients with IBD patients with UC perianal placebo placebo-controlled pregnancy primary sclerosing cholangitis probiotics proctitis randomized rectal refractory relapse remission reported resection response risk role side-effects small bowel steroids stool sulfasalazine surgery symptoms therapeutic therapy thiopurine tion toxicity TPMT transplantation treated treatment ulcerative colitis